35 research outputs found
Online Monitoring of Lactate Efflux by Multi-Channel Microfluidic Chip-Mass Spectrometry for Rapid Drug Evaluation
An online multichannel microfluidic
chip-mass spectrometry (MS)
platform was developed for cell metabolism studies. Paper-spray ionization
was employed for microsampling from different microchannels and, at
the same time, the interface for direct MS analysis without any sample
pretreatment. Near-real-time MS sensing of lactate in different microfluidic
channels could be achieved in a preprogrammed and automatic manner.
Influences of hypoxia on lactate efflux from normal cells and cancer
cells, as well as the differential inhibitory effects and dose–response
information on α-cyano-4-hydroxycinnamate on cancer cells of
different types were exhibited. The potential of further coupling
MS, complementary to optical and electrochemical techniques, to microfluidic
devices for cell studies was thus demonstrated
Determination of Ammonia in Water Based on Chemiluminescence Resonance Energy Transfer between Peroxymonocarbonate and Branched NaYF<sub>4</sub>:Yb<sup>3+</sup>/Er<sup>3+</sup> Nanoparticles
The ultraweak chemiluminescence (CL) from the reaction
of hydrogen
peroxide and carbonate is strongly enhanced by the branched NaYF<sub>4</sub>:Yb<sup>3+</sup>/Er<sup>3+</sup> nanoparticle (NP) in the
presence of aqueous ammonia. It was explained that ammonia catalyzes
the decomposition of peroxymonocarbonate, which is the product of
hydrogen peroxide mixing with bicarbonate, making the formation of
(CO<sub>2</sub>)<sub>2</sub>*, (O<sub>2</sub>)<sub>2</sub>*, and <sup>1</sup>O<sub>2</sub>. The excitation energy, carried by these emitter
intermediates, can be transferred to NaYF<sub>4</sub>:Yb<sup>3+</sup>/Er<sup>3+</sup> NP. The CL intensity is directly proportional to
the concentration of ammonia present in the solution. A flow-injection
CL system with high sensitivity, selectivity, and reproducibility
is proposed for the determination of aqueous ammonia. The proposed
method exhibited advantages in a larger linear range from 0.5 ÎĽmol
L<sup>–1</sup> to 50 μmol L<sup>–1</sup> and a
lower detection limit of 1.1 × 10<sup>–8</sup> mol L<sup>–1</sup> (S/N = 3). This method has been successfully applied
to the evaluation of ammonia in water samples with recoveries from
95% to 108%. The relative standard deviations are 1.8% and 4.1% for
intra-assay and inter-assay precision, respectively
Plasmon-Assisted Enhancement of the Ultraweak Chemiluminescence Using Cu/Ni Metal Nanoparticles
Cu/Ni nanoparticles (NPs) with stable fluorescence and
excellent
water dispersion were synthesized through a facile aqueous solution
method with a similar Kirkendall effect. Ultraweak chemiluminescence
(CL) from the oxidation reaction between sodium hydrogen carbonate
(NaHCO<sub>3</sub>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in neutral medium was significantly enhanced by 60 ± 5 nm
Cu/Ni NP with a copper and nickel molar ratio of 1:2. The enhancement
of the time-dependent CL was dependent on the composition of the NP
and the order of reagent addition. On the basis of studies of CL emission
spectra, electron spin resonance spectra, UV–vis absorption,
and fluorescence spectra, a mechanism of plasmon-assisted metal catalytic
effect for this metal NP (MNP)-enhanced CL was proposed. The surface
plasmons of MNP can obtain energy from chemical reaction, forming
the activated MNP (MNP*), which was coupled to ·OH radical to
produce the new adduct ·OH-MNP*. The ·OH-MNP* can accelerate
the reaction rate of HCO<sub>3</sub><sup>–</sup> for the generation
of emitter intermediate (CO<sub>2</sub>)<sub>2</sub>*, which can lead
the enhanced CL for the overall reaction
Aggregation-Induced Structure Transition of Protein-Stabilized Zinc/Copper Nanoclusters for Amplified Chemiluminescence
A stable, water-soluble fluorescent Zn/Cu nanocluster (NC) capped with a model protein, bovine serum albumin (BSA), was synthesized and applied to the reaction of hydrogen peroxide and sodium hydrogen carbonate. A significantly amplified chemiluminescence (CL) from the accelerated decomposition of peroxymonocarbonate (HCO<sub>4</sub><sup>–</sup>) by the nanosluster was observed. The CL reaction led to a structure change of BSA and aggregation of Zn/Cu NCs. In the presence of H<sub>2</sub>O<sub>2</sub>, Zn/Cu–S bonding between BSA scaffolds and the encapsulated Zn/Cu@BSA NC was oxidized to form a disulfide product. Zn/Cu@BSA NCs were prone to aggregate to form larger nanoparticles without the protection of scaffolds. It is revealed that the strong CL emission was initiated from the catalysis of Zn/Cu@BSA NC and the surface plasmon coupling of the formed Zn/Cu nanoparticles in a single chemical reaction. This amplified CL was successfully exploited for selective sensing of hydrogen peroxide in environmental samples
Qualitative and Quantitative Analysis of Tumor Cell Metabolism via Stable Isotope Labeling Assisted Microfluidic Chip Electrospray Ionization Mass Spectrometry
In this work, a stable isotope labeling assisted microfluidic
chip
electrospray ionization mass spectrometry (SIL-chip–ESI-MS)
platform for qualitative and quantitative analysis of cell metabolism
was developed. Microfluidic cell culture, drug-induced cell apoptosis
analysis, and cell metabolism measurements were performed simultaneously
on the specifically designed device. MCF-7 cells were cultivated in
vitro and exposed in anticancer agent (genistein and genistein-<i>d</i><sub>2</sub>) for cell-based drug assay. A dual-isotopic
labeling was presented for effective qualitative analysis of multiplex
metabolites. Interestingly, three coeluting pairs of isotopomers appeared
with an <i>m</i>/<i>z</i> difference of two. Despite
complex biological matrixes, they can be easily recognized and identified
by chip–ESI-MS/MS, which significantly facilitates candidate
biomarker discovery. The quantitative performance of this system was
evaluated using genistein as a model drug by means of stable isotope
dilution analysis. The linear equation obtained is <i>y</i> = 0.06<i>x</i> – 3.38 × 10<sup>–3</sup> (<i>R</i><sup>2</sup> = 0.995) at the dynamic range from
0.5 to 40 ÎĽM. The detection limit is 0.2 ÎĽM. The method
shows an excellent stability of 2.2% relative standard deviation (RSD)
and a good repeatability of 5.5% RSD. Our results have successfully
demonstrated the capability of selective and quantitative analysis
of cell-based drug absorption and metabolites with high stability,
sensitivity, and repeatability on the chip–ESI-MS system. Consequently,
the present device shows promise as a high-throughput, low-cost, and
online platform for cell metabolism studies and drug screening processes
Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum-4
<p><b>Copyright information:</b></p><p>Taken from "Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum"</p><p></p><p>International Journal of Biological Sciences 2007;3(5):274-280.</p><p>Published online 20 Apr 2007</p><p>PMCID:PMC1865090.</p><p>© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.</p
Evaluation of the Absorption of Methotrexate on Cells and Its Cytotoxicity Assay by Using an Integrated Microfluidic Device Coupled to a Mass Spectrometer
An integrated microfluidic device was developed for high-throughput
drug screening with an online electrospray ionization quadrupole time-of-flight
mass spectrometer (ESI-Q-TOF MS). The multiple gradient generator
followed by an array of microscale cell culture chambers and on-chip
solid-phase extraction (SPE) columns for sample pretreatment prior
to mass analysis was integrated in the device which was fabricated
in one single step. By using the combination system, the process for
characterization of drug absorption and evaluation of cytotoxicity
could be simultaneously realized. To validate the feasibility, the
absorption of methotrexate and its effects on HepG2 and Caco-2 cells
were investigated. With the increasing concentration of drugs, the
percentage of apoptotic cells appeared in a dose-dependent fashion.
By comparison with the results obtained from ESI-Q-TOF MS analysis
and cytotoxicity assay, we found that higher intracellular drug concentration
resulted in increased cell cytotoxicity. The technique presented herein
provides an easy protocol to screen drugs rapidly with low drug consumption,
high throughput, and high sensitivity
Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum-3
<p><b>Copyright information:</b></p><p>Taken from "Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum"</p><p></p><p>International Journal of Biological Sciences 2007;3(5):274-280.</p><p>Published online 20 Apr 2007</p><p>PMCID:PMC1865090.</p><p>© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.</p
Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum-1
<p><b>Copyright information:</b></p><p>Taken from "Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum"</p><p></p><p>International Journal of Biological Sciences 2007;3(5):274-280.</p><p>Published online 20 Apr 2007</p><p>PMCID:PMC1865090.</p><p>© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.</p
Microfluidic Chip-Based Modeling of Three-Dimensional Intestine–Vessel–Liver Interactions in Fluorotelomer Alcohol Biotransformation
Plyfluoroalkyl
substance (PFAS), featured with incredible persistence
and chronic toxicity, poses an emerging ecological and environmental
crisis. Although significant progress has been made in PFAS metabolism
in vivo, the underlying mechanism of metabolically active organ interactions
in PFAS bioaccumulation remains largely unknown. We developed a microfluidic-based
assay to recreate the intestine–vessel–liver interface
in three dimensions, allowing for high-resolution, real-time images
and precise quantification of intestine–vessel–liver
interactions in PFAS biotransformation. In contrast to the scattered
arrangement of vascular endothelium on the traditional d-polylysine-modified
two-dimensional (2D) plate, the microtubules in our three-dimensional
(3D) platform formed a dense honeycomb network through the ECM, with
longer tubular structures. Additionally, the slope culture of epithelial
cells in our platform exhibited a closely arranged and thicker cell
layer than the planar culture. To dynamically monitor the metabolic
crosstalk in the intestinal–vascular endothelium–liver
interaction under exposure to fluorotelomer alcohols (FTOHs), we combined
the chip with a solid-phase extraction-mass spectrometry (SPE-MS)
system. Our findings revealed that endothelial cells were involved
in the metabolic process of FTOHs. The transformation of intestinal
epithelial and hepatic epithelial cells produces toxic metabolite
fluorotelomer carboxylic acids (FTCAs), which circulate to endothelial
cells and affect angiogenesis. This system shows promise as an enhanced
surrogate model and platform for studying pollutant exposure as well
as for biomedical and pharmaceutical research